STE (Steris) Retained Earnings : $2,475 Mil (As of Mar. 2025)

View and export this data going back to 1992. Start your Free Trial

What is Steris Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Steris's retained earnings for the quarter that ended in Mar. 2025 was $2,475 Mil.

Steris's quarterly retained earnings increased from Sep. 2024 ($2,268 Mil) to Dec. 2024 ($2,386 Mil) and increased from Dec. 2024 ($2,386 Mil) to Mar. 2025 ($2,475 Mil).

Steris's annual retained earnings increased from Mar. 2023 ($1,912 Mil) to Mar. 2024 ($2,088 Mil) and increased from Mar. 2024 ($2,088 Mil) to Mar. 2025 ($2,475 Mil).

Steris Retained Earnings Historical Data

The historical data trend for Steris's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Retained Earnings Chart

Steris Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Retained Earnings

Get a 7-Day Free Trial

1,939.41

1,999.24

1,911.53

2,087.65

2,475.33

Steris Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Retained Earnings	Get a 7-Day Free Trial															2,087.65	2,178.09	2,268.33	2,385.66	2,475.33

Steris Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Steris (NYSE:STE) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Steris Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (NYSE:STE) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

S1TE34:Brazil

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris.com

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Executives

Cary L Majors	officer: VP, N America Com Operations	5960 HEISLEY ROAD, MENTOR OH 44060
Michael J Tokich	director, officer: Sr. Vice Pres., CFO	C/O STERIS CORP, 5960 HEISLEY RD, MENTOR OH 44060
Christopher S Holland	director	ARAMARK CORP, 1101 MARKET ST 29TH FLOOR, PHILADELPHIA PA 19107
Julia Madsen	officer: Senior VP, Life Sciences	5960 HEISLEY ROAD, MENTOR OH 44060
Renato Tamaro	officer: V.P. & Corporate Treasurer	5960 HEISLEY ROAD, MENTOR OH 44060
Cynthia L Feldmann	director	17 WINTHROP ROAD, WAYLAND MA 01778
Mohsen Sohi	director	C/O STERIS CORPORATION, 5960 HEISLEY ROAD, MENTOR OH 44060
Karen L Burton	officer: VP, Controller & CAO	5960 HEISLEY ROAD, MENTOR OH 44060
Jacqueline B Kosecoff	director	5960 HEISLEY ROAD, MENTOR OH 44060
Richard C Breeden	director	100 SOUTH WACKER, SUITE 1800, CHICAGO IL 60606
Esther M. Alegria	director	2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
John Adam Zangerle	director, officer: Sr. VP, Gen Counsel, and Sec.	5960 HEISLEY ROAD, MENTOR OH 44060
Andrew Xilas	officer: SVP and GM, Dental	5960 HEISLEY ROAD, MENTOR OH 44060
Paul Edward Martin	director	C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, SUITE 100, BLUE BELL PA 19422
David B Lewis	director